05 Compliance

The regulatory file for manganese bisglycinate

Technical document 05 · Reviewed 2026-11-19 · Manganese Bisglycinate

On this page
  1. What the file contains
  2. European Union
  3. United States
  4. Contaminants and intake references
  5. Label and claims
  6. Documents the file needs
  7. Checklist before the first order

The regulatory file for manganese bisglycinate is built around the exact form, the destination and the finished-product route. The buyer's regulatory team confirms whether the supplement route or the food-additive route applies. This page sets out the framework, the limits and the documents to hold, so the specification and the shipment can be checked as one file.

In one line

A compliant file starts with the exact form on the label and ends with the destination's current text; the certificate sits in the middle.

What the file contains

Four questions shape the file. Which material and specification version are being purchased? Which lot is up for release, and what numbers does its COA carry? Which limits and label rules govern the finished product? What happens if the source, process or pack changes? The COA covers the lot, the TDS covers the specification and the SDS covers handling; no single one of them settles the route.

Allergen, GMO, irradiation, animal-derived, origin and residual-solvent statements belong in the file, together with any customer-specific declaration. If a statement is missing for the lot, say so before the order rather than at the port.

European Union

The EU framework begins with Directive 2002/46/EC on food supplements, which sets positive lists of vitamins and minerals and the forms in which they may be used. The current Annex II text, including amendments, decides whether the exact form is listed; the buyer's team confirms the entry and the specification attached to it. Food law, labelling and contaminant rules run alongside that listing.

Regulation (EU) No 1169/2011 sets the food information rules and the nutrient reference values. Manganese has an NRV of 2 mg, so the label percentage is calculated against that figure. Regulation (EC) No 1924/2006 governs nutrition and health claims, Regulation (EU) No 432/2012 lists the authorised health claims, and Regulation (EU) 2023/915 sets the contaminant limits. The consolidated text, not a summary, is the reference as of this review.

Whether a novel-food authorisation or a specific national rule applies is a separate question. The supplement route and the food-additive route are not interchangeable, and the buyer's regulatory team confirms the route for the destination.

United States

The US framework begins with the dietary-supplement definition in section 201(ff) of the Federal Food, Drug and Cosmetic Act. The ingredient file should name the basis it relies on: a new dietary ingredient notification, a GRAS conclusion, or evidence of marketing before 15 October 1994. The supplier can support that file, but the buyer decides whether the basis extends to the finished product and its intended use.

21 CFR 111 sets the cGMP requirements, including identity testing of components, supplier qualification and batch records. 21 CFR 101.36 sets the Supplement Facts panel; the Daily Value for manganese is 2.3 mg for adults and children four years and older. The source line should name manganese bisglycinate and match the specification.

Structure/function claims are allowed when they are truthful, not misleading and substantiated, with the DSHEA disclaimer required by 21 CFR 101.93 and the notification to the FDA within 30 days of first marketing. No disease-related claim is allowed. The FDA does not approve the supplement or the label before sale, so the marketer's file carries the evidence.

Contaminants and intake references

Contaminants are judged at the finished-product level, not only in the drum. The table gives a working starting point for an EU supplement file; the destination text and the daily dose settle the final figure.

Limits and references to confirm for the finished product
ParameterWorking referenceEvidence the file needs
Lead (Pb)3.0 mg/kg in the finished supplementResult, method, limit and the dose conversion
Cadmium (Cd)1.0 mg/kg in the finished supplementResult and any category exception
Mercury (Hg)0.10 mg/kg in the finished supplementResult and method
Arsenic (As)No harmonised EU limit; the buyer sets oneAgreed limit, method and detection limit
Manganese (Mn)EFSA 2023 safe level: 8 mg/day for adults, total intakeDose per portion and total intake from all sources

The manganese row is an intake reference, not a contaminant limit. EFSA's 2023 opinion established a safe level of intake of 8 mg/day for adults, with lower levels for other groups. The finished-product dose is the brand's calculation. Check the current EFSA text and the national guidance. In the US there is no federal maximum level for manganese in dietary supplements; the cGMP rule sets process and identity requirements rather than a metal limit.

Label and claims

An EU nutrition claim such as “source of manganese” has a condition: the daily portion must supply at least 15% of the 2 mg NRV, which is 0.3 mg. A health claim must match the authorised wording and conditions in Regulation (EU) No 432/2012; the list contains manganese entries, and the brand's reviewer checks that the finished product meets the condition. No disease-related claim is allowed.

In the US, a structure/function claim describes the role of a nutrient in normal structure or function. It must be truthful, not misleading and substantiated, and it carries the DSHEA disclaimer; the marketer notifies the FDA within 30 days of first marketing. No disease-related claim is allowed. The label names the form, and the claim file is separate from the certificate.

Claims are not approved by a certificate, and a claim does not rewrite the specification. Keep the wording, the substantiation and the artwork in one version-controlled file.

Documents the file needs

  • Specification: form, CAS number, assay basis, manganese range, loss on drying, particle size, contaminants and microbiology.
  • Batch COA: method and result for each line, not only a pass statement.
  • TDS and SDS for the grade and pack.
  • Contaminant report against the destination limits, with an arsenic limit where the buyer sets one.
  • Allergen, GMO, irradiation, animal-derived input and residual-solvent statements for the lot.
  • Origin record and change-control statement for the source, process and pack.
  • Nutrition worksheet and claim file for the finished product.

A specification and a COA are not the same document: the first states what will be supplied, the second records what one lot measured. Holding only one leaves half the file unanswered.

Checklist before the first order

  • The specification version, CAS number and exact form are stated.
  • COA, TDS, SDS, allergen, GMO, origin and residual-solvent statements are present.
  • Contaminant results have been converted to the finished-product dose.
  • The manganese dose is checked against the EFSA safe level and the destination rules.
  • Label and claim have been reviewed for the destination market.
  • Source, process and pack sit under change control.

The product hub carries the catalog specification; the COA page explains the lot certificate; the identity page covers the analytical evidence; the EU regulatory note and the US regulatory note give the framework references; the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation